BioXcel Therapeutics (BTAI) FCF Margin Growth (1y) (2023 - 2026)
BioXcel Therapeutics (BTAI) FCF Margin Growth (1y) (2023 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 74.00 |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | -1,043.00 |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | -573.00 |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 734.00 |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 301.00 |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | -45,890.00 |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | 407.00 |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 610.00 |
| 10 | BioXcel Therapeutics | 25.46 Mn | 25.46 Mn | -77,000.00 | 143,593.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 143,593.00 |
| Dec 31, 2025 | -150,461.00 |
| Sep 30, 2025 | -1.15 Mn |
| Jun 30, 2025 | -838,007.00 |
| Mar 31, 2025 | -412,618.00 |
| Dec 31, 2024 | 309,824.00 |
| Sep 30, 2024 | 338,712.00 |
| Jun 30, 2024 | 626,108.00 |
| Mar 31, 2024 | 2.24 Mn |
| Dec 31, 2023 | 909,046.00 |
| Sep 30, 2023 | 1.17 Mn |